Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 10/10

vs
industry
vs
history
Cash to Debt No Debt
GMED's Cash to Debt is ranked higher than
85% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. GMED: No Debt )
Ranked among companies with meaningful Cash to Debt only.
GMED' s 10-Year Cash to Debt Range
Min: N/A  Med: 10000.00 Max: No Debt
Current: No Debt

Warning: Division by zero in /home/gurufocu/public_html/include/common_stock_functions_2.php on line 6484
N/A
No Debt
Equity to Asset 0.84
GMED's Equity to Asset is ranked higher than
82% of the 284 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. GMED: 0.84 )
Ranked among companies with meaningful Equity to Asset only.
GMED' s 10-Year Equity to Asset Range
Min: 0.83  Med: 0.86 Max: 0.88
Current: 0.84
0.83
0.88
Interest Coverage No Debt
GMED's Interest Coverage is ranked higher than
79% of the 168 Companies
in the Global Medical Devices industry.

( Industry Median: 10000.00 vs. GMED: No Debt )
Ranked among companies with meaningful Interest Coverage only.
GMED' s 10-Year Interest Coverage Range
Min: 9999.99  Med: 10000.00 Max: 9999.99
Current: No Debt
F-Score: 3
Z-Score: 14.76
M-Score: -1.87
WACC vs ROIC
2.84%
29.14%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 29.33
GMED's Operating margin (%) is ranked higher than
96% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 3.07 vs. GMED: 29.33 )
Ranked among companies with meaningful Operating margin (%) only.
GMED' s 10-Year Operating margin (%) Range
Min: 23.4  Med: 29.37 Max: 30.43
Current: 29.33
23.4
30.43
Net-margin (%) 19.42
GMED's Net-margin (%) is ranked higher than
91% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 1.62 vs. GMED: 19.42 )
Ranked among companies with meaningful Net-margin (%) only.
GMED' s 10-Year Net-margin (%) Range
Min: 15.79  Med: 18.90 Max: 19.5
Current: 19.42
15.79
19.5
ROE (%) 16.99
GMED's ROE (%) is ranked higher than
84% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 3.09 vs. GMED: 16.99 )
Ranked among companies with meaningful ROE (%) only.
GMED' s 10-Year ROE (%) Range
Min: 15.98  Med: 19.78 Max: 43.04
Current: 16.99
15.98
43.04
ROA (%) 14.29
GMED's ROA (%) is ranked higher than
93% of the 322 Companies
in the Global Medical Devices industry.

( Industry Median: -0.62 vs. GMED: 14.29 )
Ranked among companies with meaningful ROA (%) only.
GMED' s 10-Year ROA (%) Range
Min: 13.54  Med: 16.80 Max: 36.91
Current: 14.29
13.54
36.91
ROC (Joel Greenblatt) (%) 68.78
GMED's ROC (Joel Greenblatt) (%) is ranked higher than
91% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 3.55 vs. GMED: 68.78 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
GMED' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 59.22  Med: 72.20 Max: 139.86
Current: 68.78
59.22
139.86
» GMED's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

GMED Guru Trades in Q3 2014

Paul Tudor Jones 52,495 sh (+86.01%)
Joel Greenblatt 1,165,867 sh (+26.69%)
Jim Simons 852,500 sh (+8.41%)
Steven Cohen Sold Out
» More
Q4 2014

GMED Guru Trades in Q4 2014

Steven Cohen 789,800 sh (New)
Paul Tudor Jones 44,990 sh (-14.30%)
Joel Greenblatt 571,767 sh (-50.96%)
Jim Simons 250,100 sh (-70.66%)
» More
Q1 2015

GMED Guru Trades in Q1 2015

Louis Moore Bacon 100,000 sh (New)
Steven Cohen 523,600 sh (-33.70%)
Joel Greenblatt 245,402 sh (-57.08%)
Paul Tudor Jones 19,032 sh (-57.70%)
Jim Simons 98,300 sh (-60.70%)
» More
Q2 2015

GMED Guru Trades in Q2 2015

Steven Cohen 659,525 sh (+25.96%)
Jim Simons Sold Out
Louis Moore Bacon Sold Out
Paul Tudor Jones 17,765 sh (-6.66%)
Joel Greenblatt 185,214 sh (-24.53%)
» More
» Details

Insider Trades

Latest Guru Trades with GMED

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 24.28
GMED's P/E(ttm) is ranked higher than
56% of the 154 Companies
in the Global Medical Devices industry.

( Industry Median: 28.00 vs. GMED: 24.28 )
Ranked among companies with meaningful P/E(ttm) only.
GMED' s 10-Year P/E(ttm) Range
Min: 12.95  Med: 24.67 Max: 35.54
Current: 24.28
12.95
35.54
Forward P/E 20.96
GMED's Forward P/E is ranked higher than
51% of the 96 Companies
in the Global Medical Devices industry.

( Industry Median: 23.15 vs. GMED: 20.96 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 24.60
GMED's PE(NRI) is ranked higher than
56% of the 153 Companies
in the Global Medical Devices industry.

( Industry Median: 28.00 vs. GMED: 24.60 )
Ranked among companies with meaningful PE(NRI) only.
GMED' s 10-Year PE(NRI) Range
Min: 12.96  Med: 24.65 Max: 35.64
Current: 24.6
12.96
35.64
P/B 3.73
GMED's P/B is ranked lower than
62% of the 288 Companies
in the Global Medical Devices industry.

( Industry Median: 3.03 vs. GMED: 3.73 )
Ranked among companies with meaningful P/B only.
GMED' s 10-Year P/B Range
Min: 2.45  Med: 3.84 Max: 4.94
Current: 3.73
2.45
4.94
P/S 4.69
GMED's P/S is ranked lower than
68% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 2.77 vs. GMED: 4.69 )
Ranked among companies with meaningful P/S only.
GMED' s 10-Year P/S Range
Min: 2.48  Med: 4.29 Max: 5.61
Current: 4.69
2.48
5.61
PFCF 49.32
GMED's PFCF is ranked lower than
70% of the 118 Companies
in the Global Medical Devices industry.

( Industry Median: 32.61 vs. GMED: 49.32 )
Ranked among companies with meaningful PFCF only.
GMED' s 10-Year PFCF Range
Min: 18.52  Med: 29.56 Max: 55.02
Current: 49.32
18.52
55.02
POCF 28.23
GMED's POCF is ranked lower than
64% of the 154 Companies
in the Global Medical Devices industry.

( Industry Median: 21.13 vs. GMED: 28.23 )
Ranked among companies with meaningful POCF only.
GMED' s 10-Year POCF Range
Min: 12.65  Med: 20.62 Max: 31.53
Current: 28.23
12.65
31.53
EV-to-EBIT 14.61
GMED's EV-to-EBIT is ranked higher than
71% of the 160 Companies
in the Global Medical Devices industry.

( Industry Median: 21.01 vs. GMED: 14.61 )
Ranked among companies with meaningful EV-to-EBIT only.
GMED' s 10-Year EV-to-EBIT Range
Min: 6.7  Med: 15.00 Max: 21.3
Current: 14.61
6.7
21.3
Current Ratio 4.96
GMED's Current Ratio is ranked higher than
77% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 2.42 vs. GMED: 4.96 )
Ranked among companies with meaningful Current Ratio only.
GMED' s 10-Year Current Ratio Range
Min: 4.88  Med: 6.66 Max: 10.12
Current: 4.96
4.88
10.12
Quick Ratio 3.86
GMED's Quick Ratio is ranked higher than
74% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 1.92 vs. GMED: 3.86 )
Ranked among companies with meaningful Quick Ratio only.
GMED' s 10-Year Quick Ratio Range
Min: 3.82  Med: 5.60 Max: 8.29
Current: 3.86
3.82
8.29
Days Inventory 262.56
GMED's Days Inventory is ranked lower than
79% of the 282 Companies
in the Global Medical Devices industry.

( Industry Median: 130.22 vs. GMED: 262.56 )
Ranked among companies with meaningful Days Inventory only.
GMED' s 10-Year Days Inventory Range
Min: 125.66  Med: 253.41 Max: 266.18
Current: 262.56
125.66
266.18
Days Sales Outstanding 52.10
GMED's Days Sales Outstanding is ranked higher than
77% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 69.40 vs. GMED: 52.10 )
Ranked among companies with meaningful Days Sales Outstanding only.
GMED' s 10-Year Days Sales Outstanding Range
Min: 50.59  Med: 51.95 Max: 58.04
Current: 52.1
50.59
58.04

Valuation & Return

vs
industry
vs
history
Price/Net Cash 30.09
GMED's Price/Net Cash is ranked lower than
77% of the 102 Companies
in the Global Medical Devices industry.

( Industry Median: 12.83 vs. GMED: 30.09 )
Ranked among companies with meaningful Price/Net Cash only.
GMED' s 10-Year Price/Net Cash Range
Min: 6.32  Med: 13.33 Max: 31.3
Current: 30.09
6.32
31.3
Price/Net Current Asset Value 7.05
GMED's Price/Net Current Asset Value is ranked lower than
53% of the 208 Companies
in the Global Medical Devices industry.

( Industry Median: 6.85 vs. GMED: 7.05 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
GMED' s 10-Year Price/Net Current Asset Value Range
Min: 3.2  Med: 5.91 Max: 7.36
Current: 7.05
3.2
7.36
Price/Tangible Book 4.55
GMED's Price/Tangible Book is ranked lower than
56% of the 262 Companies
in the Global Medical Devices industry.

( Industry Median: 4.09 vs. GMED: 4.55 )
Ranked among companies with meaningful Price/Tangible Book only.
GMED' s 10-Year Price/Tangible Book Range
Min: 2.65  Med: 4.48 Max: 5.51
Current: 4.55
2.65
5.51
Price/Median PS Value 1.08
GMED's Price/Median PS Value is ranked lower than
55% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 1.06 vs. GMED: 1.08 )
Ranked among companies with meaningful Price/Median PS Value only.
GMED' s 10-Year Price/Median PS Value Range
Min: 0.59  Med: 1.03 Max: 1.32
Current: 1.08
0.59
1.32
Price/Graham Number 2.18
GMED's Price/Graham Number is ranked lower than
51% of the 136 Companies
in the Global Medical Devices industry.

( Industry Median: 2.22 vs. GMED: 2.18 )
Ranked among companies with meaningful Price/Graham Number only.
GMED' s 10-Year Price/Graham Number Range
Min: 1.24  Med: 2.24 Max: 2.96
Current: 2.18
1.24
2.96
Earnings Yield (Greenblatt) (%) 6.86
GMED's Earnings Yield (Greenblatt) (%) is ranked higher than
85% of the 311 Companies
in the Global Medical Devices industry.

( Industry Median: 0.40 vs. GMED: 6.86 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
GMED' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 4.7  Med: 6.70 Max: 15
Current: 6.86
4.7
15

Analyst Estimate

Dec15 Dec16 Dec17
Revenue(Mil) 528 572 600
EPS($) 1.05 1.18 1.25
EPS without NRI($) 1.05 1.18 1.25

Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
Traded in other countries:GM0N.Germany,
Globus Medical Inc was incorporated in Delaware in March 3, 2003. The Company is a medical device company focused exclusively on the design, development and commercialization of musculoskeletal implants. It is currently focused on implants that promote healing in patients with spine disorders. All of its products fall into one of two categories: Innovative Fusion or Disruptive Technologies. The Company's Innovative Fusion products address a spinal fusion surgical procedures. Spinal fusion is a surgical procedure to correct problems with the individual vertebrae, the interlocking bones making up the spine, by preventing movement of the affected bones. It currently offers over 120 products for the treatment of spine disorders. Products in Innovative Fusion includes: CREO, a convenient non-threaded locking cap design that eases building of thoracolumbar fixation constructs to readily adapt to the patient's anatomy and condition, for a range of clinical applications. XPAND, FORTIFY, FORTIFY-I corpectomy devices that incorporate smooth expansion capability, have a range of size options for optimal fit, and are manufactured from titanium or radiolucent polyetheretherketone. COALITION and INDEPENDENCE stand-alone interbody fusion devices, simplify the surgical technique by reducing steps and hardware while providing confident stabilization. Disruptive Technologies represent a shift in the treatment of spine disorders by allowing for novel surgical procedures, improvements to existing surgical procedures, and the treatment of spine disorders by new physician specialties, and surgical intervention earlier in the continuum of care. Products in Disruptive Technologies includes: MIS products which enable a surgeon to perform a procedure less invasively to minimize tissue disruption and maximize native anatomy, for patient recovery and fewer approach-related complications. For example, MARS 3V retractor system facilitates smaller incisions with the use of positionable radiolucent retractor blades to access the surgical site and to allow both direct and radiographic visualization. CALIBER, RISE and recently launched LATIS expandable interbody spacers are designed for reliable, minimally disruptive delivery through small MIS incisions with streamlined implants and instruments. REVOLVE pedicle screw system is designed for MIS screw and rod insertion through small incisions, and utilizes a convenient non-threaded locking cap design. TRANSITION, provide for stabilization that is less rigid than traditional pedicle screw systems for more natural load distribution to help promote fusion while maintaining stability. Other products included are SECURE-C, SECURE-CR, KINEX, MICROFUSE, SHIELD, AFFIRM, among others. Company's competitors include: Medtronic, the DePuy Synthes Companies, Stryker and NuVasive. Alphatec Spine, Orthofix International, Zimmer, LDR, among others. As of December 31, 2013, the Company owned 188 issued U.S. patents and had applicat
» More Articles for GMED

Headlines

Articles On GuruFocus.com
Weekly CEO Sells Highlight: Globus Medical Inc, Diplomat Pharmacy Inc, Zendesk Inc, and Amicus Thera Mar 28 2015 

More From Other Websites
Globus Medical, Inc. Earnings Q2, 2015 Aug 27 2015
GLOBUS MEDICAL INC Financials Aug 07 2015
GMED SHAREHOLDER ALERT –The Law Offices of Vincent Wong Launch an Investigation into Globus... Aug 03 2015
GLOBUS MEDICAL INC Files SEC form 10-Q, Quarterly Report Jul 31 2015
Edited Transcript of GMED earnings conference call or presentation 30-Jul-15 9:30pm GMT Jul 31 2015
Globus Medical meets 2Q profit forecasts Jul 30 2015
Globus Medical meets 2Q profit forecasts Jul 30 2015
Globus Medical Inc Earnings Call scheduled for 5:30 pm ET today Jul 30 2015
GLOBUS MEDICAL INC Files SEC form 8-K, Results of Operations and Financial Condition Jul 30 2015
Globus Medical Reports Second Quarter 2015 Results Jul 30 2015
Q2 2015 Globus Medical Inc Earnings Release - After Market Close Jul 30 2015
Globus Medical Schedules Second Quarter 2015 Earnings Release and Conference Call Jul 09 2015
Globus Medical Adds RISE-L to Suite of Expandable Spacers - Analyst Blog Jul 06 2015
Globus Medical Announces RISE-L, an Expandable Lateral Interbody Fusion Device Jul 01 2015
GMED SHAREHOLDER ALERT -The Law Offices of Vincent Wong Launch an Investigation into Globus Medical,... Jun 22 2015
GLOBUS MEDICAL INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 18 2015
GLOBUS MEDICAL INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant Jun 09 2015
Globus Medical, Inc. Engages Grant Thornton LLP as Independent Auditor Jun 09 2015
Globus Medical to Participate at Investor Events in June Jun 02 2015
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of... May 28 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK